Gilead Sciences (GILD) vs. AMGN and VRTX: Can Oncology Growth and HIV Strength Drive a New Growth Era Beyond Acquisitions?

Is GILD a good stock to buy? We came across a bullish thesis on Gilead Sciences, Inc. on Astute Optics – US’s Substack. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc.’s share was trading at $156.51 as of October 20th 2026. GILD’s trailing and forward P/E were 17.84 and 15.55 respectively according to Yahoo Finance.

This isn’t the first time we see a biotechnology company pitched as a great investment. GILD shares gained 28.86% over the last 12...